Clinical Trial Update: Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Preoperative Hexakapron shows reduced bleeding in bariatric surgery, though the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery-related Bleeding
• Obesity

Drugs mentioned

• Hexakapron (tranexamic acid derivative)

Snippet

Sponsor: Sheba Medical Center | Conditions: Intra-Operative Injury - Other, Post Operative Hemorrhage | Phase 3 | Status: TERMINATED